Versatile analog device offers fast inflation and ease of use, streamlining patient care
PolarityTE Secures $22.5 Million Financing to Advance SkinTE Phase III Pivotal Study in Diabetic Foot Ulcers
Study to Evaluate SOR102, a Novel Oral Dual-Acting Antibody Targeting TNF⍺ and IL-23 (p19) for Inflammatory Bowel Disease
Major Milestone for EVŌQ Nano’s Biotech Arm Targeting Antibiotic-Resistant Bacterial Infections Linked to Cystic Fibrosis and Other Lung Diseases
Dr. Bearss will be the Chair of the “Drug Discovery for Neurodegenerative Diseases” session, on May 23.
Joe Wright Appointed President, Expands Deep Bench of Leadership Team Talent; Supports “Continued Growth Initiatives” Program.
New products broaden Merit’s leadership in embolotherapy.
Parents in the United Kingdom will soon have access to Owlet’s Dream Sock with UKCA certification.
Groundbreaking at-home pivotal trial of a much-anticipated therapeutic device is underway.
BioHive-2, an NVIDIA DGX SuperPOD with NVIDIA DGX H100 systems, ranked #35 in the TOP500 list of the most powerful supercomputers in the world across all industries as of May 2024.
ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs.
Tether Takes Strategic Stake in Leading Brain-Computer-Interface Company Blackrock Neurotech